Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Yuanhua Biotechnology is a high-tech enterprise focused on the development and industrialization of bioactive materials, specifically high-purity collagen and bone-related health products. The company integrates R&D, production, and sales, targeting therapeutic areas such as orthopedics, dermatology, and clinical nutrition. Their core technology involves the extraction and purification of collagen for use in medical devices, functional foods, and cosmetic applications. Jiangsu Yuanhua operates a large-scale manufacturing base in Yancheng, China, and maintains collaborations with several Chinese research institutions to advance regenerative medicine solutions. The company's product line includes medical-grade collagen sponges and bioactive peptides designed to support joint health and tissue repair.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Yuanhua.